Alan F. Denenberg

Davis Polk is advising McKesson Corporation on its acquisition of RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health…

Davis Polk advised ViewRay, Inc. in a direct registered offering of 8,382,643 shares of ViewRay’s common stock for proceeds to ViewRay of approximately $50 million. ViewRay’s common stock…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by NetApp, Inc. of $400 million aggregate principal amount of its 2.000% senior notes…

Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 18,018,000 shares of Class A common stock of Roku, Inc., including all…

Davis Polk advised Equinix, Inc. on its SEC-registered offering of €1 billion aggregate principal amount of 2.875% senior notes due 2025. Equinix, Inc. intends to use approximately …

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Workday, Inc. of $1.15 billion aggregate principal amount of its 0.25%…

Davis Polk advised the underwriters in connection with an $882 million public offering of GoDaddy Inc. Class A common stock.  Based in Scottsdale, Arizona, GoDaddy is a technology…

Davis Polk is advising J.P. Morgan Securities LLC and Citigroup Global Markets Inc. as financial advisers to Rockwell Collins, Inc. in connection with its $23 billion merger with United…

Davis Polk advised the initial purchasers on a Rule 144A offering by Jazz Investments I Limited, a wholly owned subsidiary of Jazz Pharmaceuticals plc, of $500 million aggregate…

Davis Polk advised the manager and the global structuring agent and coordinator in connection with Intel’s SEC-registered offering in Taiwan of $640 million aggregate principal…